期刊文献+

宝鸡地区绝经后女性乳腺癌特点分析 被引量:1

Analysis of characteristics of breast cancer in postmenopausal female in Baoji area
下载PDF
导出
摘要 目的分析宝鸡地区绝经后女性乳腺癌临床、影像、病理特点,为此地区乳腺癌筛查、早诊断、早治疗提供依据。方法选择2016年7月至2018年3月在宝鸡市中心医院影像科行双侧乳腺钼靶X线摄影检查,并经穿刺或手术后病理证实为乳腺癌的女性患者119例,记录患者年龄、腺体类型、绝经情况、乳腺癌激素受体(ER、PR)及Her-2表达情况。比较绝经前、后乳腺癌患者的年龄、乳腺腺体类型分布情况及ER、PR、Her-2表达情况。结果宝鸡地区119例女性乳腺癌中,绝经后患者共67例,平均年龄为(58.24±2.05)岁;绝经前患者共52例,平均年龄为(43.67±1.83)岁;绝经前、后乳腺癌患者的乳腺腺体类型分布情况比较,差异有统计学意义(P=0.000),绝经后女性以脂肪型及散在纤维腺体型腺体为主,绝经前女性以不均匀腺体型及极度致密型腺体为主;绝经前患者的ER、PR阳性表达率均明显高于绝经后患者,差异具有统计学意义(P<0.05);绝经前、后患者的Her-2阳性表达率比较,差异不具有统计学意义(P>0.05)。结论宝鸡地区绝经前、后女性的乳腺癌高发年龄不同,进行乳腺癌筛查时应注意月经情况,绝经后女性以脂肪型及散在纤维腺体型乳腺为主;绝经后女性ER、PR阳性表达比例低于绝经前女性,内分泌治疗效果不如绝经前女性。 Objective To analyze the clinical, imaging and pathological characteristics of breast cancer in postmenopausal female in Baoji area, so as to provide basis for breast cancer screening, early diagnosis and early treatment in that area.Methods From July 2016 to March 2018, 119 female patients with breast cancer accepted mammography of bilateral mammary gland and confirmed by puncture or pathology after operation in the imaging department of Baoji central hospital were selected. The age, gland type, menopause, hormone receptor of breast cancer(ER, PR) and Her-2 expression were recorded, and the age, gland type of breast, expression of ER, PR and Her-2 between premenopausal and postmenopausal patients with breast cancer were compared. Results Among 119 female patients with breast cancer in Baoji area, 67 were postmenopausal, with an average age of(58.24±2.05) years;52 were premenopausal, with an average age of(43.67±1.83)years. The distribution of breast gland types between premenopausal and postmenopausal breast cancer patients had significant difference(P=0.000). The main types of glands in postmenopausal women were adipose glands and scattered fibrous glands, while those in premenopausal women were uneven glands and extremely dense. The positive expression rates of ER and PR in premenopausal patients were higher than those in postmenopausal patients, and the differences were statistically significant(P <0.05);there was no significant difference in Her-2 positive expression rates between premenopausal and postmenopausal patients(P >0.05). Conclusion There are different ages of high incidence of breast cancer in premenopausal and postmenopausal women in Baoji area. Menstruation should be paid attention to in breast cancer screening. The main types of glands in postmenopausal women are adipose glands and scattered fibrous glands;the positive expression rates of ER and PR in postmenopausal women are lower than those in premenopausal women, and the effect of endocrine therapy is not as good as that in premenopausal women.
作者 张宝荣 任转琴 张雷 索凌云 ZHANG Bao-rong;REN Zhuan-qin;ZHANG Lei;SUO Ling-yun(Baoji Central Hospital,Baoji 721008;Baoji High-tech People's Hospital,Baoji 721013,China)
出处 《临床医学研究与实践》 2020年第3期5-7,共3页 Clinical Research and Practice
基金 宝鸡市卫健委科研计划课题(No.2018-11)
关键词 宝鸡地区 乳腺癌 绝经 Baoji area breast cancer menopause
  • 相关文献

参考文献8

二级参考文献61

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2顾雅佳,汪晓红,肖勤,杨文涛,曾炜,唐峰,毛健,郑晓静,彭卫军,冯晓源.乳腺导管原位癌及其微浸润的磁共振成像评价[J].中华放射学杂志,2007,41(3):248-253. 被引量:43
  • 3杨文琦,蒲践一,李瑞伟,赵光明,徐卫国.309例乳腺癌患者年龄与病理分型的相关性探讨[J].山东医药,2007,47(17):67-67. 被引量:2
  • 4全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤死亡报告-全国第三次死因回顾抽样调查[M].北京:人民卫生出版社,2010,6.
  • 5Jemal A, Murray T, Ward E, et al. Cancer statistics, CA Cancer [J] . J Clin, 2005, 55 (1): 10.
  • 6STEWART B W, KLEIHUES P. World Cancer Report[M]. Lyon: IARC Press, 2003: 188-193.
  • 7FERLAY J, SHIN H R, BRAY F, et al. GLOBOCAN 2008 vl. 2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [DB/OL]. Lyon: International Agency for Research on Cancer, 201 012012-02-01]. http: //globocan. iarc. fr.
  • 8全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.2010中国肿瘤登记年报(中国肿瘤登记地区2007年肿瘤发病死亡)[M].北京:军事医学科学出版社,2011:1-14.
  • 9Rossouw JE,Anderson GL,Prentice RL,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women' s Health Initiative randomized controlled trial. JAMA, 2002, 288(3) :321-333.
  • 10Lupulescu A. Estrogen use and cancer incidence: a review. Cancer Invest, 1995,13 (3) :287-295.

共引文献450

同被引文献9

引证文献1

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部